Kreos Capital Group

Kreos Capital Group is a private debt manager, not a family office. It functions as an institutional investment firm focused on venture debt and growth lending to European technology and life sciences companies. Its fee structure and sourcing model align with asset management rather than single- or multi-family office norms.

Kreos specializes in venture debt, growth loans, and sometimes mezzanine or unitranche facilities. These are typically structured as term loans with warrants or other equity-linked enhancements, designed for companies that have revenue or high growth potential but may not yet be profitable. The firm often co-invests alongside equity investors.

The firm focuses on Europe, with active coverage of the Nordic region, the UK, and DACH countries. Kreos has offices in London and Stockholm, among other locations. The geographic focus has been consistent across its transaction history.

Based on public records, Kreos Capital Group primarily invests in Europe. There is no publicly disclosed evidence of direct investments in the United States or Asia. The firm's known deployment is concentrated in European growth-stage companies.

Kreos sources deals through a proprietary network of relationships with venture capital firms, investment banks, and corporate advisors across Europe. The firm typically participates in syndicated transactions alongside equity investors, often initiating contact through its direct outreach to growth-stage companies in its target sectors.

Kreos typically provides loans ranging from several million euros to tens of millions, targeting growth-stage companies that have raised venture capital but may not yet have positive cash flow. The firm generally avoids early-stage or pre-revenue investments, focusing on later-stage growth and expansion rounds.

Public information does not indicate that Kreos Capital Group is directly affiliated with a single family office or specific institutional parent. It operates as an independent private debt manager, though some of its limited partners may include family offices and institutional allocators.